# Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction

> **NCT02262078** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 26 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Sodium Nitrite Inhalation Solution
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02262078
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-08-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02262078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02262078, "Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02262078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*